Stress management techniques, whether meditation, breathing exercises, time in nature, or whatever works for you, are not just good general advice
Popular weight loss medications Sources: PlushCare is dedicated to providing you with accurate and trustworthy health information
SURMOUNT-1: Tirzepatide for Obesity The SURMOUNT-1 trial (NEJM, 2022) studied tirzepatide weight loss in 2,539 adults with obesity (without diabetes) over 72 weeks: STEP 1: Semaglutide for Obesity The STEP 1 trial (NEJM, 2021) studied semaglutide 2.4mg in 1,961 adults with obesity (without diabetes) over 68 weeks: Cross-Trial Summary Comparing across trials (with the caveat that indirect comparison has limitations): tirzepatide 15mg produced about 6 percentage points more weight loss than semaglutide 2.4mg over similar timeframes
The pharmaceutical company Novo Nordisk told CNN in July that GLP-1 agonists have been studied in detail and in use for several years
Panel a : The proportion of participants achieving total body fat mass reduction thresholds at Week 48 by dual-energy X-ray absorptiometry (DXA) is based on logistic regression with multiple imputation using a treatment-regimen estimand
